BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Everest Medicines receives full payment from Gilead for Trodelvy transaction, boosting cash reserves

"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...

March 28, 2023 | News

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial r...

March 15, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

March 14, 2023 | News

Merck Achieves Profitable Growth in Challenging Fiscal 2022

Fiscal 2022 Group net sales rise 12.9% to € 22.2 billion EBITDA pre up 12.2% to € 6.8 billion EBITDA pre margin at 30.8% “Big 3&rdquo...

March 13, 2023 | News

Everest Medicines unaffected by Silicon Valley Bank developments.

The company's cash held at SVB is substantially less than 1% of its total cash balance, and amounts not covered by the Federal Deposit Insurance Corporatio...

March 13, 2023 | News

Allorion Therapeutics Raises $50M in Series B Financing for Precision Medicine in Oncology and Autoimmune Diseases

The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...

March 11, 2023 | News

Allorion Therapeutics raises $50M for precision medicine in oncology and autoimmune diseases

The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...

March 10, 2023 | News

Bionomics Released Quarterly Activities and Cashflow Report

Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...

January 31, 2023 | News

Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28

Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb....

January 31, 2023 | News

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit of KRW 312.8 billion. FY'22 consolidated revenue of&nb...

January 27, 2023 | News

Metabolon Secures $25 Million of Funding to Accelerate Growth

The proceeds will be used for general corporate purposes, helping Metabolon further accelerate commercialization activities and continue advancing its well...

January 25, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

January 23, 2023 | News

Stay Connected